
“Even when my scans look good, I don’t get my old life back” Tammy is grateful to be here, but she wants more: time, memories, and to grow old with her husband. @motherofswans @OncogeneCancer @YoungLungCancer #HumansOfLungCancer

We are a patient-driven organization, dedicated to improving the life expectancy & quality of life for ALK-positive cancer patients worldwide. #StrongerTogether

“Even when my scans look good, I don’t get my old life back” Tammy is grateful to be here, but she wants more: time, memories, and to grow old with her husband. @motherofswans @OncogeneCancer @YoungLungCancer #HumansOfLungCancer

Glad to see this FDA approval for Neladalkib, a next gen TKI drug for ALK Lung Cancer. This is an important next line of treatment option for me if and when Lorlatinib stops working. 🙏
Neladalkib has @FDA approval! 💙 The dancing & cheering say it all. Another treatment option means so much to our ALK+ #lungcancer community. Thanks to the patients who took part in trials, the investigators & @nuvalent teams who made this possible. What does this mean to you?

BIG news for ALK+ NSCLC! FDA grants accelerated approval to neladalkib. ▫️ORR: 49% post-alectinib; 32% heavily pretreated ▫️G1202R: 68% ORR (exploratory), including post-lorlatinib ▫️AEs: ↑LFTs/CPK/Cr, vision changes, constipation, fatigue More options are always welcomed.
Today, we granted accelerated approval to a medication for previously treated locally advanced or metastatic non-squamous non-small cell lung cancer. fda.gov/drugs/cancer-approva…

Years of research went into this moment. Thanks to Those w ALK who took part in trials, the teams who ran them and @Nuvalent. @ALKPositiveinc, we’re turning up the music with you! Here’s to more approvals worldwide so more people with ALK+ #lungcancer can access neladalkib. 🎶
Neladalkib has @FDA approval! 💙 The dancing & cheering say it all. Another treatment option means so much to our ALK+ #lungcancer community. Thanks to the patients who took part in trials, the investigators & @nuvalent teams who made this possible. What does this mean to you?

Every advance in ALK+ cancer treatment starts with a new idea. @TejasPatilMD of @CUAnschutz works to match patients with the right therapy and overcome resistance. His dream: more research --> more innovation --> a brighter future for every patient. #MoreResearchMoreDreams

🚨 FDA approval in lung cancer! 🇺🇸 FDA grants accelerated approval to neladalkib for previously treated advanced ALK+ NSCLC. 📊 ALKOVE-1: ORR 31% in pretreated patients @ALKPositiveinc @UKALK1 @LUNGevity @StephenVLiu @DrJWest @n8pennell @DrJNaidoo fda.gov/drugs/cancer-approva…

Great to see neladalkib finally approved for ALK+ NSCLC! I’ve used it and found that patients tolerate it really well. I’ve also seen efficacy (including in the CNS) in some patients who’ve experienced disease progression on lorlatinib, which’s incredible! @ALKPositiveinc
The @US_FDA granted accelerated approval to the ALK inhibitor neladalkib for locally advanced or metastatic ALK-positive non-small cell lung cancer previously treated with the ALK inhibitor alectinib or two or more ALK inhibitors and chemotherapy: brnw.ch/21x79w1

Neladalkib has @FDA approval! 💙 The dancing & cheering say it all. Another treatment option means so much to our ALK+ #lungcancer community. Thanks to the patients who took part in trials, the investigators & @nuvalent teams who made this possible. What does this mean to you?

Yvonne found out she had lung cancer on a day packed with meetings. Her twins were 14. How would she tell them? Five years on, she’s still here, watching her boys grow up. She credits research, her community and the people she loves. #HumansOfLungCancer #LCAM26

Courtney from Playa del Rey, CA, has been living with ALK+ lung cancer for 5 years. It’s been a long journey, but thanks to research she has more travels ahead of her—and her dream is to see the world. Support Courtney and others like her—Donate Today: secure.qgiv.com/event/moredr…

Krista, from Florence, SC, was diagnosed with ALK+ lung cancer in 2021. For Krista, the dream is more time to love—her wish is to grow old with her husband. Support research that gives patients like her longer, fuller lives: //secure.qgiv.com/event/moredreams/donate/

The best treatment starts with the individual. Dr @bensolomon1 @petermaccc hopes for personalised #lungcancer care that gives everyone the best possible outcome. Options shaped around their cancer, needs and everyday lives. #LCAM26 @YoungLungCancer @EGFRResisters

After Kathy's stage IV ALK-positive lung cancer diagnosis, targeted therapy gave her hope for more time with family. 💙 Inspired by research, Kathy and Andrew raised over $10k to help others have more moments that matter. Help fund more moments together: secure.qgiv.com/event/moredr…

First identified less than 20 years ago, ALK+ lung cancer has seen survival grow ever longer. Thoracic surgeon @JVelottaMD of @aboutKP credits research for this exciting time for ALK+ patients. With more research, no dream is out of reach. #MoreResearchMoreDreams

We’re raising children. Falling in love. Making plans. Then people hear #lungcancer, and it can become all they see. Our faces. Our words. Our lives beyond the diagnosis. Read. Share. Get involved👉 humans-of-lung-cancer.web.ap… @YoungLungCancer @EGFRResisters #HumansOfLungCancer

Ally still wants to be part of it all. #lungcancer treatment can make tomorrow hard to predict. Keep inviting us. Let the plan change. Share her reel with the people you want to keep making plans with. @EGFRResisters @OncogeneCancer #HumansOfLungCancer